The clinical pharmacology of alkylating agents in high-dose chemotherapy

Alwin D.R. Huitema; Karen Doesburg Smits; Ron A.A. Mathôt; Jan H.M. Schellens; Sjoerd Rodenhuis; Jos H. Beijnen

doi:10.1097/00001813-200008000-00002

The clinical pharmacology of alkylating agents in high-dose chemotherapy

Alwin D.R. Huitema, Karen Doesburg Smits, Ron A.A. Mathôt, Jan H.M. Schellens, Sjoerd Rodenhuis, Jos H. Beijnen

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel recenseren › peer review

41 Citaten (Scopus)

Samenvatting

Alkylating agents are widely used in high-dose chemotherapy regimens in combination with hematological support. Knowledge about the pharmacokinetics and pharmacodynamics of these agents administered in high doses is critical for the safe and efficient use of these regimens. The aim of this review is to summarize the clinical pharmacology of the alkylating agents (including the platinum compounds) in high-dose chemotherapy. Differences between conventional and high doses will be discussed. (C) 2000 Lippincott Williams and Wilkins.

Originele taal-2	Engels
Pagina's (van-tot)	515-533
Aantal pagina's	19
Tijdschrift	Anti-Cancer Drugs
Volume	11
Nummer van het tijdschrift	7
DOI's	https://doi.org/10.1097/00001813-200008000-00002
Status	Gepubliceerd - 2000
Extern gepubliceerd	Ja

Toegang tot document

10.1097/00001813-200008000-00002

Citeer dit

@article{8894ba86abd94dc1ab2536bab6f9ada0,

title = "The clinical pharmacology of alkylating agents in high-dose chemotherapy",

abstract = "Alkylating agents are widely used in high-dose chemotherapy regimens in combination with hematological support. Knowledge about the pharmacokinetics and pharmacodynamics of these agents administered in high doses is critical for the safe and efficient use of these regimens. The aim of this review is to summarize the clinical pharmacology of the alkylating agents (including the platinum compounds) in high-dose chemotherapy. Differences between conventional and high doses will be discussed. (C) 2000 Lippincott Williams and Wilkins.",

keywords = "Alkylating agents, Clinical pharmacology, High-dose chemotherapy",

author = "Huitema, {Alwin D.R.} and Smits, {Karen Doesburg} and Math{\^o}t, {Ron A.A.} and Schellens, {Jan H.M.} and Sjoerd Rodenhuis and Beijnen, {Jos H.}",

year = "2000",

doi = "10.1097/00001813-200008000-00002",

language = "English",

volume = "11",

pages = "515--533",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

TY - JOUR

T1 - The clinical pharmacology of alkylating agents in high-dose chemotherapy

AU - Huitema, Alwin D.R.

AU - Smits, Karen Doesburg

AU - Mathôt, Ron A.A.

AU - Schellens, Jan H.M.

AU - Rodenhuis, Sjoerd

AU - Beijnen, Jos H.

PY - 2000

Y1 - 2000

N2 - Alkylating agents are widely used in high-dose chemotherapy regimens in combination with hematological support. Knowledge about the pharmacokinetics and pharmacodynamics of these agents administered in high doses is critical for the safe and efficient use of these regimens. The aim of this review is to summarize the clinical pharmacology of the alkylating agents (including the platinum compounds) in high-dose chemotherapy. Differences between conventional and high doses will be discussed. (C) 2000 Lippincott Williams and Wilkins.

AB - Alkylating agents are widely used in high-dose chemotherapy regimens in combination with hematological support. Knowledge about the pharmacokinetics and pharmacodynamics of these agents administered in high doses is critical for the safe and efficient use of these regimens. The aim of this review is to summarize the clinical pharmacology of the alkylating agents (including the platinum compounds) in high-dose chemotherapy. Differences between conventional and high doses will be discussed. (C) 2000 Lippincott Williams and Wilkins.

KW - Alkylating agents

KW - Clinical pharmacology

KW - High-dose chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=0033800062&partnerID=8YFLogxK

U2 - 10.1097/00001813-200008000-00002

DO - 10.1097/00001813-200008000-00002

M3 - Review article

C2 - 11036954

AN - SCOPUS:0033800062

SN - 0959-4973

VL - 11

SP - 515

EP - 533

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

IS - 7

ER -

The clinical pharmacology of alkylating agents in high-dose chemotherapy

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit